Balanced news tone
News Sentiment
OSX sentiment intelligence
Osteopore Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
91/100 classification confidence.
directly relevant articles
high-authority source matches
+25.0% over one week, +25.0% over four weeks, trend inactive, and below fair value.
Osteopore Limited (ASX:OSX): How Is This 3D-Printed Bone Regeneration Biotech Advancing Its Commercial Pipeline?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Osteopore Limited (ASX:OSX): How Is This 3D-Printed Bone Regeneration Biotech Advancing Its Commercial Pipeline?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 01:41
- Source
- Kalkine
Osteopore achieves medical product access in Saudi Arabia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- grafa.com
Osteopore (ASX:OSX) Gains Momentum Following China Expansion Update
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Kalkine
Osteopore (ASX:OSX) shares rise by 50% as it cracks the Chinese market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Stocks Down Under
Osteopore secures landmark medical approval In China
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 25 May 2026 07:00
- Source
- grafa.com
Osteopore (ASX:OSX) is set to crack the Malaysian market - and its bigger than you may think!
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- Stocks Down Under
Osteopore (ASX:OSX) Stock Analysis: Revenue Growth, Losses, and Future Potential
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- Kalkine
Osteopore (ASX:OSX) Attracts Institutional Interest as Advance Opportunities Fund Emerges as Key Shareholder
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Mar 2026 08:00
- Source
- Kalkine
ASX Runners of the Week: Aus Strategic, Osteopore, Olympio & Riversgold
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jan 2026 08:00
- Source
- SMH.com.au
ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jan 2026 08:00
- Source
- SMH.com.au
Insights: Osteopore Ltd (ASX:OSX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 15:59
- Source
- smallcaps.com.au
Osteopore enhances strategic refocus with early cessation of dental grant project
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Mar 2025 07:00
- Source
- BiotechDispatch
Case Study: Osteopore International’s bright future as a regenerative medicine leader
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2024 01:52
- Source
- RSM Global
ASX Small Caps Lunch Wrap: Osteopore’s gone 1000% bananas, and here’s the rest of the news.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2024 07:00
- Source
- Stockhead
Osteopore Limited (ASX: OSX) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2020 04:04
- Source
- intelligentinvestor.com.au
OSX Stock Price and Chart — ASX:OSX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Sep 2019 16:05
- Source
- TradingView
Osteopore Limited (ASX:OSX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Sep 2019 12:46
- Source
- intelligentinvestor.com.au
Perth-based bone healing biotech company Osteopore soars on ASX debut
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2019 07:00
- Source
- SMH.com.au